Astrana Health, Inc.
ASTH
$37.85
$0.471.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 579.00% | 85.41% | 453.95% | 60.66% | -43.35% |
| Total Other Revenue | 53.61% | 42.53% | 97.67% | 34.57% | 54.41% |
| Total Revenue | 55.56% | 42.89% | 99.71% | 34.66% | 53.43% |
| Cost of Revenue | 56.51% | 39.16% | 111.95% | 39.74% | 66.18% |
| Gross Profit | 48.25% | 88.28% | 32.25% | 6.14% | -3.55% |
| SG&A Expenses | 45.30% | 46.63% | 37.79% | 41.09% | 9.73% |
| Depreciation & Amortization | 126.00% | 101.83% | 114.69% | -7.22% | 34.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.51% | 40.40% | 105.77% | 39.08% | 59.91% |
| Operating Income | 29.73% | 2,343.75% | 3.82% | -32.35% | -27.04% |
| Income Before Tax | 105.22% | 496.09% | -78.85% | -47.25% | -59.99% |
| Income Tax Expenses | 94.44% | -83.95% | -41.34% | -34.11% | -52.63% |
| Earnings from Continuing Operations | 111.08% | 184.38% | -94.33% | -53.28% | -63.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 177.07% | -168.16% | 75.61% | 70.58% | 123.24% |
| Net Income | 115.72% | 186.30% | -97.68% | -50.85% | -54.89% |
| EBIT | 29.73% | 2,343.75% | 3.82% | -32.35% | -27.04% |
| EBITDA | 52.60% | 284.31% | 26.39% | -27.37% | -18.15% |
| EPS Basic | 117.23% | 181.27% | -97.75% | -52.41% | -56.01% |
| Normalized Basic EPS | 76.63% | 251.67% | -33.33% | -45.70% | -41.42% |
| EPS Diluted | 109.99% | 181.27% | -97.70% | -52.50% | -55.45% |
| Normalized Diluted EPS | 72.14% | 250.83% | -32.96% | -45.58% | -41.34% |
| Average Basic Shares Outstanding | -0.72% | 6.24% | 3.21% | 3.30% | 2.56% |
| Average Diluted Shares Outstanding | 1.90% | 6.88% | 2.59% | 3.11% | 2.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.99% | -- | -- | -- | -- |